In 2024, 31.7% of adults and 29.5% of children had a diagnosed seasonal allergy, diagnosed eczema, or a diagnosed food ...

The skin is our first line of defense, and it notices everything—the dust hanging in the air, fumes from traffic, and tiny ...

Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease ...

Delgocitinib cream and dupilumab have similar efficacy at 16 weeks of treatment in patients with moderate to severe atopic hand eczema.

New Guidance Helps Parents Understand Infant Skin Vulnerability and Bacterial Imbalance A child's eczema severity often ...

A new study published in the Journal of the European Academy of Dermatology & Venerology showed that in children with severe ...

Once-daily oral ICP-332 results in large reduction in eczema scores and shows favorable safety in adults with moderate-to-severe atopic dermatitis.

NEMLUVIO is the first authorized monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling ...

KT-621 BROADEN2 Phase 2b trial in AD ongoing, with data expected by mid-2027KT-621 BREADTH Phase 2b trial in asthma initiated, with data expected ...

Research shows introducing peanuts during infancy cuts allergy risk, while eggs now surpass peanuts as the most common food ...